These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 21198568)
1. Commentary from the Refractory Headache Special Interest Section on defining the pharmacologically intractable headache for clinical trials and clinical practice. Schulman EA; Lipton R; Peterlin BL; Levin M; Grosberg BM Headache; 2010 Nov; 50(10):1637-9. PubMed ID: 21198568 [No Abstract] [Full Text] [Related]
2. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982 [TBL] [Abstract][Full Text] [Related]
3. Refractory headache: classification and nomenclature. Levin M Headache; 2008 Jun; 48(6):783-90. PubMed ID: 18549356 [TBL] [Abstract][Full Text] [Related]
4. Defining the pharmacologically intractable headache for clinical trials and clinical practice. Silberstein SD; Dodick DW; Pearlman S Headache; 2010 Oct; 50(9):1499-506. PubMed ID: 20958296 [TBL] [Abstract][Full Text] [Related]
5. Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Schulman EA; Peterlin BL; Lake AE; Lipton RB; Hanlon A; Siegel S; Levin M; Goadsby PJ; Markley HG Headache; 2009 Apr; 49(4):509-18. PubMed ID: 19245385 [TBL] [Abstract][Full Text] [Related]
6. Refractory headache: historical perspective, need, and purposes for an operational definition. Schulman EA; Brahin EJ Headache; 2008 Jun; 48(6):770-7. PubMed ID: 18479419 [TBL] [Abstract][Full Text] [Related]
7. [Sulpiride in the treatment of migraine, tension headache and associated psychosomatic disorders]. Hakkarainen H; Viukari M Duodecim; 1973 Aug; 89(22):1504-9. PubMed ID: 4587835 [No Abstract] [Full Text] [Related]
8. Botulinum toxin type A (Botox) in the treatment of migraine and other headaches. Troost BT Expert Rev Neurother; 2004 Jan; 4(1):27-31. PubMed ID: 15853612 [TBL] [Abstract][Full Text] [Related]
9. [Migraine--vasomotor headache and its therapeutic approaches]. Glaser A Med Welt; 1974 Sep; 25(36):1435-8. PubMed ID: 4612289 [No Abstract] [Full Text] [Related]
10. Clinical studies in the treatment of vascular headache. Abbott KH Med Arts Sci; 1966; 20(1):3-15. PubMed ID: 4862005 [No Abstract] [Full Text] [Related]
11. Placebo effects in treating migraine and other headaches. Diener HC Curr Opin Investig Drugs; 2010 Jul; 11(7):735-9. PubMed ID: 20597189 [TBL] [Abstract][Full Text] [Related]
13. 2010: year in review. Peroutka SJ Headache; 2011 Jan; 51(1):181-7. PubMed ID: 21198581 [TBL] [Abstract][Full Text] [Related]
14. Headache therapy with botulinum toxin: form over substance. Pakalnis A; Couch J Arch Neurol; 2008 Jan; 65(1):149-51. PubMed ID: 18195156 [No Abstract] [Full Text] [Related]
15. [Clinical experiences with polyantiaminic BC-105 Sandoz in the prevention of vasomotor headaches]. Sercl M; Vrcha L Schweiz Rundsch Med Prax; 1970 May; 59(18):679-83. PubMed ID: 4396441 [No Abstract] [Full Text] [Related]
20. Towards a definition of intractable headache for use in clinical practice and trials. Goadsby PJ; Schoenen J; Ferrari MD; Silberstein SD; Dodick D Cephalalgia; 2006 Sep; 26(9):1168-70. PubMed ID: 16919073 [No Abstract] [Full Text] [Related] [Next] [New Search]